UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in HROW — Harrow, Inc.

CIK 861177 NEW YORK, NY

Back to HROW Full portfolio

Position in HROW

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,797,094

-$956,804 QoQ

Shares Held

50,967

-9.3% QoQ

Ownership

0.137%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 45.10369454745227.ToString("F0")% Shared 0.ToString("F0")% None 54.89630545254772.ToString("F0")%

Common Shares in HROW Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $926,551,772 across 34 Drug Manufacturers - Specialty & Generic names. HROW ranks #21 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	4,398,351	$519,929,066
2	UTHR	UNITED THERAPEUTICS Corp	207,309	$122,930,085
3	NBIX	Neurocrine Biosciences Inc	571,719	$75,318,257
4	VTRS	Viatris Inc	3,964,630	$53,562,146
5	LNTH	Lantheus Holdings, Inc.	486,498	$36,900,870
6	ELAN	Elanco Animal Health Inc	1,526,922	$36,539,240
7	ALKS	Alkermes plc.	403,153	$14,255,486
8	HIMS	Hims & Hers Health, Inc.	443,527	$9,207,616

All Filings in HROW

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,797,094	50,967	-9.3%	Shares	Defined	2026-05-13
2025-12-31	$2,753,898	56,202	+4.2%	Shares	Defined	2026-02-13
2025-09-30	$2,598,586	53,935	-40.0%	Shares	Sole	2025-11-14
2025-06-30	$2,746,063	89,917	+40.2%	Shares	Defined	2025-08-14
2025-03-31	$1,706,149	64,141	+3.6%	Shares	Defined	2025-05-19
2024-12-31	$2,078,084	61,940	+89.5%	Shares	Defined	2025-02-14
2024-09-30	$1,469,202	32,678	—	Shares	Defined	2024-11-14
No filing history on record for this holder in this stock.